PHASE-II STUDY OF TENIPOSIDE IN ADENOCARCINOMA OF THE LUNG

被引：3

作者：

SORENSEN, JB ^{[1
]}

BACH, F ^{[1
]}

DOMBERNOWSKY, P ^{[1
]}

HANSEN, HH ^{[1
]}

机构：

[1] UNIV COPENHAGEN,HERLEV HOSP,DK-2730 HERLEV,DENMARK

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1991年 / 27卷 / 06期

关键词：

D O I：

10.1007/BF00685166

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A total of 26 evaluable patients with previously untreated, non-resectable adenocarcinoma of the lung were given 80 mg/m2 i.v. teniposide daily for 5 days every 3 weeks. Three partial responses (11%) were obtained that lasted for 12, 11 and 32 weeks, respectively. Leucopenia was the dose-limiting side effect, with WBC counts of < 2 x 10(9)/l being observed in 42% of patients, resulting in one septic death. At the dose and schedule used in the present study, teniposide showed only limited activity in adenocarcinoma of the lung.

引用

页码：487 / 489

页数：3

共 50 条

[21] PHASE-II STUDY OF TENIPOSIDE IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA
SCHWARTSMANN, G
SPRINZ, E
KRONFELD, M
VINHOLES, J
SANDER, E
ZAMPESE, M
PREGER, R
KALAKUN, L
BRUNETTO, AL
EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1637 - 1639
[22] A PHASE-II STUDY TO EVALUATE TAMOXIFEN IN PANCREATIC ADENOCARCINOMA
CROWSON, MC
DORRELL, A
ROLFE, EB
FIELDING, JWL
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1986, 12 (04): : 335 - 336
[23] A PHASE-II STUDY WITH TENIPOSIDE (VM26) IN PATIENTS WITH PROGRESSED OR RELAPSED SMALL CELL LUNG-CANCER (SCLC)
TUMMARELLO, D
GUIDI, F
DIFURIA, L
GRAMAZIO, A
MENICHETTI, E
CELLERINO, R
JOURNAL OF CHEMOTHERAPY, 1989, 1 (01) : 64 - 67
[24] PHASE-II STUDY OF TENIPOSIDE (VM26) IN CUTANEOUS T-CELL LYMPHOMAS
SORIO, R
TIRELLI, U
ZAGONEL, V
CARBONE, A
MONFARDINI, S
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 14 - 16
[25] A PHASE-II STUDY OF EPIRUBICIN IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE PANCREAS
AOKI, K
SHIMADA, Y
OKAZAKI, N
TAJIRI, H
NOSE, H
OKADA, S
SHIRAO, K
YOKOTA, T
YOSHIDA, S
SAITOH, D
OHKURA, H
YOSHIMORI, M
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) : 1590 - 1590
[26] A PHASE-II STUDY OF AMSA IN LUNG-CANCER
SAMSON, MK
FRAILE, RJ
BAKER, LH
TALLEY, RW
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 357 - 357
[27] PHASE-II STUDY OF AMSA IN LUNG-CANCER
SAMSON, MK
FRAILE, RJ
BAKER, LH
CUMMINGS, G
TALLEY, RW
CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 655 - 658
[28] PHASE-II EVALUATION OF MELPHALAN IN ADENOCARCINOMA OF THE PANCREAS
SMITH, DB
KENNY, JB
SCARFFE, JH
MALEY, WV
CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 917 - 918
[29] PHASE-II STUDY OF 3-DEAZAURIDINE IN ADVANCED COLORECTAL ADENOCARCINOMA
BRUNO, S
CREAVEN, PJ
LEDESMA, E
POSTER, D
YOON, J
MITTELMAN, A
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 69 - 71
[30] A PHASE-II TRIAL OF 5-FU, ADRIAMYCIN AND CISPLATIN (FAP) IN ADENOCARCINOMA OF THE LUNG
ALVAREZ, C
WOOLLEY, P
SMITH, F
VILLALBA, J
GISSELBRECHT, C
HANNOIS, A
BOIRON, M
SCHEIN, P
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 499 - 499

← 1 2 3 4 5 →